Clinical Trial Update: STREAM-Strategic Reperfusion (With Tenecteplase and Antithrombotic Treatment) Early After Myocardial Infarction [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial update for STREAM-Strategic Reperfusion using Tenecteplase with antithrombotic treatment in early myocardial infarction has completed w…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction

Drugs mentioned

• Tenecteplase (tenecteplase)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Myocardial Infarction | Phase 3 | Status: COMPLETED | Results posted: 2019-08-01